Dichloroacetate enhances Chemo-sensitivity in wild-type P53 breast cancer cells by modulating ABCG2 and NKG2DL
Abstract The chemotherapy drug called Adriamycin, often known as doxorubicin (Dox), is used to treat BC, including late stages. However, the emergence of resistance may reduce the efficacy of Dox in the treatment of BC. The objective of the current work is to assess how the stress ligands MICA, MICB...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-13608-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|